SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Delivery formulations

News headlines

News in brief

Torrent acquires Indian dermatological drugmaker Zyg

20-Jul-2015 - Torrent Pharma has added two facilities to its network through the acqusition of Zyg Pharma from the Encore Group.

Celgene boosting immune-inflammatory presence with $7.2bn Receptos deal

16-Jul-2015 - Celgene has shelled out $7.2bn (€6.6bn) to acquire Receptos which is developing an oral lymphocyte trafficking agent for multiple sclerosis and inflammatory bowel disorder.

Fresenius Kabi fined £500,000 after patient death

13-Jul-2015 - Fresenius Kabi and a UK drug manufacturer have been sentenced for supplying faulty insulin syringes which contributed to a diabetic man’s death.

'Afrezza is not the new Exubera' says MannKind in defence of low sales

08-Jul-2015 - Pfizer’s Exubera may have muddied the waters but MannKind is confident a marketing push can help its inhaled insulin product Afrezza succeed after disappointing early sales.

Oramed talking to new potential partners in China after Guangxi Wuzhou deal collapses

08-Jul-2015 - Oramed is in talks with replacement Chinese investors after Guangxi Wuzhou pulled out of a plan to sell its insulin pill ORMD-0801 in China.

Abivax's IPO to fund HIV and hep B pipeline before potential Big Pharma deal

06-Jul-2015 - In France’s largest ever biotech IPO, Abivax has raised €58m ($64m) to continue developing its HIV and Hep B candidates.

Teva pays $35m upfront for implantable drug delivery device partnership

30-Jun-2015 - Generic juggernaut Teva Pharmaceuticals has partnered with Microchips Biotech to use its implantable drug delivery device to improve outcomes for patients on chronic drug therapies.

Saneca buys Europe's only independent, US FDA approved Beta-lactams plant

25-Jun-2015 - API firm Saneca Pharmaceuticals has acquired struggling drug formulator Suir Pharma Ireland in a deal with former owner Mutares AG.

New nanotech excipient makes for better delayed-release drugs say researchers

22-Jun-2015 - Swedish scientists who developed the solubility enhancing nanotech excipient Upsalite say it can also be used to improve delayed release formulations.

South Korea mulls combining HIV drugs with antivirals to combat MERS

22-Jun-2015 - As the death toll from MERS in South Korea edged to two dozen scientists there say the outbreak is different from in Saudi Arabia and also from its the related virus SARS. 

Phos enzyme ID'd using CRISPR may lead to safer cancer meds say researchers

19-Jun-2015 - A newly identified enzyme that modifies secreted proteins could lead to safer cancer drugs and new osteoporosis treatments say scientists.

New drug delivery technologies seek to advance personalized oncology treatments

11-Jun-2015 - Ongoing research on two new drug delivery systems could help clinicians more accurately understand how certain tumors react to different treatments, according to the Journal of the American Medical Association .

update

Sobi terminates talks with unnamed suitor

08-Jun-2015 - Swedish Orphan Biovitrum AB (Sobi) has pulled out of talks with a suitor that was rumoured to be US drug giant Pfizer.

GSK breathes freely as Mylan launches Seretide generic in UK

08-Jun-2015 - GlaxoSmithKline is unconcerned about losing its position in the respiratory market as Mylan launches the first generic version of blockbuster asthma product Seretide in the UK.

Pharma R&D exodus on the Horizon? EU industry bemoans funding cuts

04-Jun-2015 - European drug industry groups have contrasted 'misguided' cuts to the Horizon 2020 budget with US plans to increase NIH funding for science R&D under the 21st Century Cures Bill.

Bubble delivery can rescue failing drug candidates, says Oxford team

02-Jun-2015 - University of Oxford scientists are saving undeliverable drugs by placing them in gas bubbles for better bioavailability and fewer side effects.

Inhalable biologics: Serendex formulates with Novozymes’ Recombumin

20-May-2015 - Serendex Pharmaceutical is a step closer to developing an inhalable biopharmaceutical for lung disease after adopting stabilising tech from Novozymes.

EMA: show clinical justification for combination drugs

20-May-2015 - The EMA has released guidelines on developing combination drugs with more than one active pharmaceutical ingredient (API).

Cancer-hunting shark proteins are the future of drug conjugation, says Almac

19-May-2015 - Almac is coupling tiny shark proteins to a cancer-killing warhead to develop an oncology drug, saying their small size makes for easy conjugation. 

EMA: clinical data may not be needed for topical comparisons

13-May-2015 - The EMA (European Medicines Agency) is changing the way it assesses quality of topical drugs for marketing authorisations.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...

Product Innovation